AGENT THAT INTERACTS WITH SERUM AMYLOID A GENE FOR THE TREATMENT OF GLAUCOMA

The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of se...

Full description

Saved in:
Bibliographic Details
Main Author WANG, WAN-HENG
Format Patent
LanguageEnglish
French
Published 23.06.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A, wherein such agents are inhibitors of p38 MAPkinase. La présente invention concerne des compositions et des procédés de traitement du glaucome, des procédés de diagnostic du glaucome et des procédés d'identification d'agents qui peuvent être utiles dans le traitement du glaucome. Plus spécifiquement, la présente invention décrit l'utilisation d'agents qui modulent l'expression de l'amyloïde A sérique, dans laquelle de tels agents sont des inhibiteurs de la MAPkinase p38.
Bibliography:Application Number: WO2010US60210